Range Cancer Therapeutics ETF Rating → Elon Musk Secret Crypto Plot Exposed (From Crypto 101 Media) (Ad) Free CNCR Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share RatingsStock AnalysisDividendHeadlinesHoldingsRatingsShort InterestSocial MediaStock AnalysisDividendHeadlinesHoldingsRatingsShort InterestSocial Media Range Cancer Therapeutics ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.CNCR Aggregate RatingModerate Buy2.73Holdings in CNCR have an aggregate rating of Moderate Buy based on 366 analyst ratings issued in the past year covering 50 companies (73.0% of the portfolio).CNCR Aggregate Price Target$30.3896.52% UpsideHigh Prediction$41.08Average Prediction$30.38Low Prediction$20.89Holdings in CNCR have an aggregate price target of $30.38 and a range of $20.89 to $41.08 covering 50 companies (73.0% of the portfolio).CNCR Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy17 Buy rating(s)Moderate Buy24 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Range Cancer Therapeutics ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 CNCR Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.05%GERNGeron$3.81-1.6%4 of 5 stars2.80$6.10 60.1%5Analyst RevisionGap Down2.27%IBRXImmunityBio$7.92-4.1%0 of 5 stars2.00$6.00 -24.2%1Gap Down2.17%CGEMCullinan Oncology$27.72-5.6%3 of 5 stars3.00$31.00 11.8%7Insider Selling2.12%ACRVAcrivon Therapeutics$8.23-1.3%3 of 5 stars2.88$22.63 174.9%8Upcoming Earnings2.08%DCPHDeciphera Pharmaceuticals$25.370.0%3 of 5 stars2.30$24.17 -4.7%10Analyst Revision2.05%ELVNEnliven Therapeutics$24.49-0.9%2 of 5 stars3.00$34.00 38.8%1Insider Selling2.01%JANXJanux Therapeutics$55.37-10.0%3 of 5 stars3.00$61.33 10.8%7Analyst ForecastGap Down1.91%NUVBNuvation Bio$3.22+0.9%3 of 5 stars3.00$6.60 105.0%51.63%DAWNDay One Biopharmaceuticals$16.41-3.9%3 of 5 stars2.86$37.67 129.5%7Analyst ForecastNews Coverage1.59%RVMDRevolution Medicines$38.31-1.5%3 of 5 stars3.10$41.20 7.5%10Gap Down1.52%TSVT2seventy bio$4.48-9.7%2 of 5 stars2.38$13.17 193.9%8News Coverage1.46%HCMHUTCHMED$19.47+0.1%2 of 5 stars2.75$29.70 52.5%4Positive News1.44%ITOSiTeos Therapeutics$12.20-0.9%1 of 5 stars3.00$30.33 148.6%31.44%AGENAgenus$11.47-4.5%4 of 5 stars3.00$70.00 510.3%3Analyst ForecastNews Coverage1.44%YMABY-mAbs Therapeutics$13.61-20.9%1 of 5 stars2.33$16.57 21.8%6Gap DownHigh Trading Volume1.42%XNCRXencor$23.66-2.4%4 of 5 stars2.89$36.00 52.2%9Upcoming Earnings1.41%BPMCBlueprint Medicines$108.78+0.2%1 of 5 stars2.50$100.31 -7.8%16Analyst ForecastInsider SellingAnalyst RevisionNews Coverage1.40%MRKMerck & Co., Inc.$129.48-0.7%5 of 5 stars2.58$131.33 1.4%121.38%LYELLyell Immunopharma$2.50-1.6%2 of 5 stars2.50$5.50 120.0%2Analyst ForecastNews Coverage1.38%MRUSMerus$47.09-3.4%1 of 5 stars3.00$56.33 19.6%11Upcoming EarningsNews Coverage1.38%BCYCBicycle Therapeutics$23.62+2.3%2 of 5 stars2.86$46.86 98.4%7Earnings Report1.35%TYRATyra Biosciences$18.03+0.5%0 of 5 stars2.67$22.00 22.0%3Gap Down1.34%AURAAura Biosciences$7.39-1.3%1 of 5 stars3.00$21.00 184.2%3News Coverage1.32%IPHAInnate Pharma$2.63+2.3%2 of 5 stars3.00$9.75 270.7%1Upcoming Earnings1.31%ERASErasca$2.15-1.4%2 of 5 stars2.80$7.83 264.3%5News CoveragePositive News1.29%SMMTSummit Therapeutics$4.96-6.6%2 of 5 stars3.00$7.50 51.2%2Analyst Forecast1.28%SDGRSchrödinger$23.22-2.1%3 of 5 stars2.67$42.80 84.3%9Gap Down1.28%IMCRImmunocore$61.32+0.5%3 of 5 stars2.87$80.92 32.0%15Analyst RevisionNews CoverageGap Down1.28%PGENPrecigen$1.33-3.6%3 of 5 stars2.33$10.00 651.9%3News Coverage1.28%MORMorphoSys$17.96+0.1%0 of 5 stars2.38$11.78 -34.4%81.28%INBXInhibrx$34.44+0.1%2 of 5 stars2.00$27.00 -21.6%2Upcoming EarningsNews CoveragePositive News1.27%GLUEMonte Rosa Therapeutics$5.26-7.4%2 of 5 stars2.67$11.00 109.1%31.27%MGNXMacroGenics$14.66-8.7%4 of 5 stars2.89$18.00 22.8%9Gap Down1.27%BNTXBioNTech$90.13-0.8%3 of 5 stars2.27$118.82 31.8%11Analyst ForecastOptions Volume1.27%FHTXFoghorn Therapeutics$5.98+6.2%2 of 5 stars2.67$14.50 142.5%3Upcoming EarningsAnalyst ForecastAnalyst RevisionNews CoverageGap Up1.27%EXELExelixis$21.59-2.5%5 of 5 stars2.63$26.33 22.0%16Analyst Revision1.27%SNDXSyndax Pharmaceuticals$22.38-3.5%3 of 5 stars2.90$34.42 53.8%10News CoverageGap Down1.27%RAPTRAPT Therapeutics$7.98-1.2%4 of 5 stars2.50$25.67 221.6%12Positive News1.25%VORVor Biopharma$1.85+5.1%2 of 5 stars3.00$13.50 629.7%51.24%GMABGenmab A/S$28.80-1.7%3 of 5 stars2.38$48.50 68.4%131.24%REGNRegeneron Pharmaceuticals$955.76-1.5%4 of 5 stars2.70$981.71 2.7%201.24%SWTXSpringWorks Therapeutics$42.26-7.6%1 of 5 stars3.00$68.83 62.9%6Earnings ReportAnalyst Forecast1.22%STROSutro Biopharma$4.28+0.7%5 of 5 stars3.00$12.50 192.1%8Analyst ForecastNews CoverageGap Up1.22%NRIXNurix Therapeutics$13.98-1.3%2 of 5 stars2.83$21.33 52.6%6Gap Down1.21%KURAKura Oncology$20.55-2.5%3 of 5 stars2.88$28.28 37.6%8Earnings ReportAnalyst Forecast1.21%IGMSIGM Biosciences$9.34-5.9%4 of 5 stars2.50$17.44 86.8%8Upcoming EarningsNews CoverageGap Down1.20%IDYAIDEAYA Biosciences$41.41-3.1%3 of 5 stars3.00$47.50 14.7%12Earnings ReportAnalyst ForecastNews CoverageGap Down1.20%KYMRKymera Therapeutics$38.50+0.2%0 of 5 stars2.50$41.10 6.8%12Earnings Report1.18%IMTXImmatics$10.63-0.8%0 of 5 stars3.001News Coverage1.15%IOVAIovance Biotherapeutics$13.39-4.2%5 of 5 stars3.00$24.64 84.0%10Upcoming EarningsOptions Volume This page (NASDAQ:CNCR) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressObama’s Forever Term [exposed]Porter & CompanyThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Range Cancer Therapeutics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
